References
- Rittié L. Fibrosis: methods and Protocols. In: Methods in Molecular Biology. New York: Springer New York.; 2017.
- Jia Q, Lei Y, Chen S, Liu S, Wang T, Cheng Y. Circulating inflammatory cytokines and risk of idiopathic pulmonary fibrosis: a Mendelian randomization study. BMC Pulm Med. 2023;23(1):369. doi:10.1186/s12890-023-02658-3
- Salton F, Ruaro B, Confalonieri P, Confalonieri M. Epithelial-mesenchymal transition: a major pathogenic driver in idiopathic pulmonary fibrosis? Medicina. 2020;56(11):608. doi:10.3390/medicina56110608
- Barratt SL, Creamer A, Hayton C, Chaudhuri N Idiopathic Pulmonary Fibrosis (IPF): an Overview; 2018. Available from: https://www.mdpi.com/2077-0383/7/8/201. Acce
- Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209–218. doi:10.1172/JCI24282
- Tuleta I, Frangogiannis NG. Diabetic fibrosis. Bioch et Bioph Acta. 2021;1867(4):166044.
- Wernig G, Chen SY, Cui L, et al. Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci. 2017;114(18):4757–4762. doi:10.1073/pnas.1621375114
- Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4(8):583–594. doi:10.1038/nri1412
- Navickas R, Petric VK, Feigl AB, Seychell M. Multimorbidity: what do we know? What should we do? J Comorb. 2016;6(1):4–11. doi:10.15256/joc.2016.6.72
- Starfield B. Challenges to primary care from co- and multi-morbidity. Prim Health Care Res Develop. 2011;12(1):1–2. doi:10.1017/S1463423610000484
- Massen GM, Allen RJ, Leavy OC, et al. Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases. QJM: Int J Med. 2023;116(6):429–435. doi:10.1093/qjmed/hcad050
- Wolf A, Dedman D, Campbell J, et al. Data resource profile: clinical practice research datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740–1740g. doi:10.1093/ije/dyz034
- Diabetes UK. New diabetes prevalence figures for England; 2023. Available from: https://www.diabetes.org.uk/about_us/news/new-diabetes-prevalence-figures-for-england. Accessed May 29, 2024.
- Chron’s & Colitis UK. New research shows over 1 in 123 people in UK living with Crohn’s or Colitis; 2023. Available from: https://crohnsandcolitis.org.uk/news-stories/news-items/new-research-shows-over-1-in-123-people-in-uk-living-with-crohn-s-or-colitis. Accessed May 29, 2024.
- Freeman K, Ryan R, Parsons N, Taylor-Phillips S, Willis BH, Clarke A. The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA medical research database. BMC Gastroenterol. 2021;21(1):139. doi:10.1186/s12876-021-01716-6
- Haque A, Hughes M. Raynaud’s phenomenon. Clin Med Lond. 2020;20(6):580–587. doi:10.7861/clinmed.2020-0754
- Ruaro B, Confalonieri M, Salton F, et al. The relationship between pulmonary damage and peripheral vascular manifestations in systemic sclerosis patients. Pharmaceuticals. 2021;14(5):403. doi:10.3390/ph14050403
- Rogers PAW, D’Hooghe TM, Fazleabas A, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335–346. doi:10.1177/1933719108330568